Dysphagia Management Market by Product (Drugs (Proton Pump Inhibitors), Feeding Tubes, Nutritional Solutions)
Industry: Healthcare
Published Date: March-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 178
Report ID: PMRREP12988
The Global revenue from the Dysphagia Management Market stands at US$ 4.2 Billion in 2022, with the global market expected to grow at a CAGR of 6.1% to reach a valuation of approximately US$ 8.1 Billion by the end of 2033.
|
Market Size (2023) |
US$ 4.5 Billion |
|
Projected Market Value (2033) |
US$ 8.1 Billion |
|
Global Market Growth Rate (2023 to 2033) |
6.1% CAGR |
|
Market Share of Top 5 Countries |
64.3% |
As assessed by Persistence Market Research, the nutritional solutions product segment held a market share of around 56.9% in the global market, in 2022. Overall, dysphagia management market sales account for approximately 77.8% of revenue share in the global throat lozenges market, which was valued at US$ 5.4 Billion in 2022.
The global market recorded a historic CAGR of 5.3% in the last 8 years from 2014 to 2022.
Dysphagia management is the process of treating swallowing difficulties, which can be brought on by a number of illnesses, including cancer, Parkinson's disease, and stroke. Dietary changes, physical activity, and, in certain situations, medication therapies may all be a part of the management.
Dysphagia is also one of the most often occurring side effects of prolonged cigarette smoking. With six million deaths caused by tobacco use each year, the market for dysphagia management is steadily expanding due to an uptick in oropharyngeal cancer cases. The management of dysphagia in the general and juvenile population has become crucial due to the disastrous effects of choking.
In terms of sales outlook, there is a demand for innovative dysphagia management products and services that can improve patient outcomes and reduce healthcare costs. Companies that can offer effective and efficient solutions, as well as demonstrate the value of their products, are likely to succeed in this market. Companies that can provide education and training on dysphagia management may have an advantage in the market.
The market for dysphagia management has been expanding gradually over the past ten years as a result of a number of causes, including an ageing population, an increase in neurological illnesses, and technical developments in the treatment of dysphagia.
Impedance technology's inclusion to measure bolus transit and esophagus luminal diameter was a logical step forward in the classification of motor patterns, which had previously only been evaluated in terms of contractile and pressurization patterns. Impedance in its original form was a straightforward dichotomous evaluation of bolus transit that gave no insight into the distinction between objective and subjective outcomes. Two other methods that support high-resolution manometry (HRM) have since evolved are functional luminal imaging probe (FLIP) panometry and high-resolution impedance manometry.
The global market is likely to show high growth over the coming years at a CAGR of 6.1% and reach a global market size of US$ 8.1 Billion by 2033.
“Increasing Healthcare Expenditure”
The main aspect affecting the dysphagia market's growth rate is the increase in healthcare spending, which helps to develop its infrastructure.
The market for dysphagia will also grow as a result of increasing initiatives by governmental and private groups to raise awareness. The increased disposable income and rising demand for dysphagia management in healthcare services and medical facilities. The rising number of smokers who will become hooked throughout the forecast period is one of the prominent factors pushing the global market.
The need for dysphagia management goods and services is being driven by the increased prevalence of dysphagia, particularly among the older population. The market is expanding as a result of the creation of cutting-edge dysphagia management tools such as fibreoptic endoscopic evaluation of swallowing (FEES) systems, neuromuscular electrical stimulation devices, and video fluoroscopy systems.
Nasogastric tubes and percutaneous endoscopic gastrostomy (PEG) tubes are more common and in high demand as the major treatments for dysphagia, which has given local businesses the chance to offer products at affordable prices.
The rapid market entry of generic medications in low-income nations is facilitated by the ease of manufacturing, the accessibility of raw ingredients at low costs, and lower expenses.
“Side Effects and Discomfort of Dysphagia Drugs and Tubes”
Drugs and tubes for dysphagia are likely to have unpleasant side effects that will slow the market's expansion. Proton pump inhibitors, a class of medicines used to treat dysphagia, are linked to a number of risks, including a higher risk of hip fracture from reduced iron and calcium absorption and a higher risk of opportunistic infections with Streptococcus pneumoniae and Clostridium difficile from weakened natural gut flora.
Nasogastric or percutaneous endoscopic gastrostomy tube insertion may cause throat irritation, cramps, edema, diarrhea, nausea, vomiting, and regurgitation of food and medications. It is anticipated that the market's expansion will be constrained by the challenge of determining the precise etiology of dysphagia.
Researchers across the globe have noted the lack of consistency in the documentation of dysphagia-related facts. Evaluation of the disease is incomplete, fragmented, and lacks consistency. Several dysphagia assessments' validity and reliability are frequently questioned by clinicians.
Access to third-party payers is known to be hampered by this, as they frequently question clinicians and doctors about the effectiveness and pathophysiology of the disease. Poor patient treatment compliance in the case of swallowing difficulties frequently stems from dissatisfaction with and accessibility to thickened liquids. Dehydration, weight loss, weakness, respiratory illnesses, and a higher risk of falling are among the consequences that are anticipated to result from decreased treatment compliance.
The high cost of dysphagia control devices is also one of the biggest barriers to market growth. Another issue is the lack of qualified healthcare workers who can handle dysphagia, which could result in less-than-ideal treatment results.
Why is the United States Market Booming?
“Rising Prevalence of Dysphagia and High Level of Healthcare Spending”
The United States accounted for around 26.2% market share in the global market in 2022.
Due to the rising prevalence of dysphagia and the high level of healthcare spending in this country, the United States dominates the dysphagia market.
The increasing attention that key players are giving to cutting-edge technologies is anticipated to drive this region's market growth rate. The effects of dysphagia on health outcomes and quality of life are becoming more and more clear to medical professionals, patients, and carers. The demand for dysphagia management goods and services can rise as a result of this raised awareness in the country.
Will Japan Be a Lucrative Market for Dysphagia Management?
“Rise in Swallowing Difficulties and Availability of Products and Services”
The Japan market held around 17.1% market share of the global market in 2022.
The market is extremely competitive, with a number of domestic and international businesses providing a wide range of goods and services. Danone S.A., Fresenius Kabi AG, and Nestle Health Science are some of the predominant participants in the Japanese market.
As a result of the rise in swallowing difficulties, the Japanese market for dysphagia management is anticipated to expand. There are many products and services available on the market, and the fierce rivalry creates many opportunities for innovation and expansion.
How is China Emerging as a Prominent Market?
“Increasing Healthcare Initiatives by Government and Increasing Use of Novel Technologies”
China held a market share of about 11.0% of the East Asia market in 2022.
The public health initiatives of the Chinese government are anticipated to increase demand for dysphagia management goods and services. The general public's and healthcare professionals' growing knowledge of the illness is also anticipated to support market expansion.
It is also, anticipated that increasing the use of cutting-edge technology, including telemedicine and electronic medical records, will enhance dysphagia diagnosis and treatment, spurring market expansion.
Which Product is Driving Demand within the Global Market?
“Rising Prevalence of Swallowing Problems”
The nutritional solution product type segment held around 56.9% share of the total market in 2022.
Nutritional supplements are of several types which include thickeners, beverages, and purees that are often used in patients with swallowing disorders. Nutritional solutions offer a secure and efficient means to enhance oral intake and avoid malnutrition, and the use of nutritional products for dysphagia treatment has grown in popularity. They also play a critical role in dysphagia management providing individuals with dysphagia with the necessary nutrients and making it easier for them to swallow food and liquids.
The need for nutritional remedies is anticipated to expand as knowledge of dysphagia treatment continues to rise. This can therefore fuel the expansion of the dysphagia management market by expanding the market's total size and opening up new avenues for product development and innovation.
Which Indication is Largely Adopted within the Global Market?
“Rising Cases of Oropharyngeal Dysphagia in Elderly Population”
Oropharyngeal Dysphagia compounds held around 80.4% share of the total market in 2022.
Oropharyngeal dysphagia is a condition in which a problem with the throat or pharynx makes it difficult to swallow food, liquids, and saliva. Several variables, including neurological illnesses, stroke, cancer, and aging, can contribute to this syndrome. The market for dysphagia management is expanding since oropharyngeal dysphagia is becoming more common in the senior population.
The market for dysphagia management is also expanding as a result of rising oropharyngeal dysphagia prevalence, increased awareness of dysphagia, and the development of novel goods and services.
Which Distribution channel is Widely in Focus in the Global Market?
“Increasing Need for Medication for Dysphagia Management”
The hospital pharmacies distribution channel holds a share of about 40.6% in 2022, globally.
Doctors' prescriptions for drugs to treat dysphagia must be filled by hospital pharmacists. They include pharmaceuticals that ease the tension in the muscles used for swallowing, lessen throat irritation, and increase the efficiency of the esophagus. In order to guarantee that patients receive the proper drug, dosage, and usage instructions, the pharmacy team is essential. Hospital pharmacies also offer drugs, dietary supplements, and other items that assist in managing the symptoms of dysphagia.
Hospital pharmacists offer medications to treat symptoms like pain, irritation, and reflux, which can make dysphagia worse.
Specialized medical equipment that can aid patients in managing their dysphagia may be available from hospital pharmacies. For instance, they might give patients feeding tubes or other tools that let them get food directly into their stomachs.
Manufacturer plays an important role in creating awareness. To scale themselves companies are now focused on acquisitions and mergers. Manufacturers are focused on product innovation and development which is evident by the recent launches. Universities are also collaborating with manufacturers to produce products that can help in contributing to the management of dysphagia.
The data points mentioned above only pertain to the companies' market focus on dysphagia.
Some key instances of development include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the dysphagia management market, which are available in the full report.
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2014 to 2022 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Indication:
Distribution Channel:
Region:
To know more about delivery timeline for this report Contact Sales
The global market is currently valued at US$ 4.2 Billion in 2022.
The global market estimates for 2023 is US$ 4.5 Billion.
The global market is set to reach valuation of around US$ 8.1 Billion by the end of 2033.
Sales of the market are set to witness growth at a CAGR of 6.1% between 2023 and 2033.
Demand for the global market increased at a 5.3% CAGR from 2014 – 2022.
The U.S., China, Japan, India, and Germany account for most demand within the market, currently holding around 64.3% market share.
The U.S. accounts for a 26.2% share of the global market in 2022.
Japan accounts for a 17.1% share of the global market in 2022.
The China market held a share of about 11.0% in the global dysphagia management market in 2022.
